Foxo1-flox Mouse
Common Name
Foxo1-flox
제품 ID
S-CKO-17420
Backgroud
C57BL/6NCya
품종 계통계통 ID
CKOCMP-56458-Foxo1-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Foxo1-flox Mouse (카탈로그 번호 S-CKO-17420)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Foxo1-flox
품종 계통계통 ID
CKOCMP-56458-Foxo1-B6N-VA
유전자명
제품 ID
S-CKO-17420
유전자 별칭
Afxh, FKHR, Fkhr1, Foxo1a
배경
C57BL/6NCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 3
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000053764
NCBI 전사체 ID
NM_019739
타겟 영역
Exon 2
유효 영역 크기
~1.9 kb
유전자 연구 개요
FoxO1, short for Forkhead box O1, is a crucial transcription factor that mediates insulin→PI3K→Akt signaling, governing diverse cellular processes such as cell cycle arrest, apoptosis, and DNA repair [3,6]. It is involved in multiple biological functions like metabolism, cell differentiation, and maintaining tissue homeostasis, and is associated with various diseases including fibrosis, diabetes, obesity, and cancers [3,4,5,6,7]. Genetic models, especially KO/CKO mouse models, are valuable in studying its functions.
In endometrial research, FoxO1 is considered a decidualization marker in endometrial stromal cells as it regulates the transcription of decidual prolactin and insulin-like growth factor-binding protein 1 genes. Epithelial FoxO1 is a novel endometrial receptivity marker, and its loss of function causes endometrial neoplasia. In endothelium, its expression coincides with increased vascular permeabilization during early pregnancy [1].
In liver fibrosis studies, increased FoxO1 expression and activation were observed in carbon tetrachloride (CCL4)-induced fibrosis. Hepatic FoxO1 deletion in F1KO mice largely attenuated CCL4-induced liver injury, fibrosis, inflammation, and decreased TGF-β1 levels compared to control mice [3].
In age-related osteoporosis, FOXO1 signaling, which is downregulated in aging macrophages, plays a key role. Blocking FOXO1 signaling aggravates bone loss and macrophage senescence, while lipoteichoic acid treatment elevates FOXO1 signaling via the β-catenin pathway [2].
In the intestine, FOXO1 deficiency in ILC3s drives hyperactivation and gut inflammation. FOXO1 promotes the transcription of neuropeptide receptor VIPR2 and inhibits ADRA2A, balancing ILC3s activation [8].
In conclusion, FoxO1 is essential for maintaining physiological functions in multiple tissues. Model-based research, especially KO/CKO mouse models, has revealed its significant roles in endometrial remodeling, liver fibrosis, osteoporosis, and intestinal homeostasis. Understanding FoxO1 functions provides potential therapeutic targets for related diseases such as endometrial neoplasia, liver fibrosis, and age-related osteoporosis [1,2,3,8].
References:
1. Adiguzel, Dileyra, Celik-Ozenci, Ciler. . FoxO1 is a cell-specific core transcription factor for endometrial remodeling and homeostasis during menstrual cycle and early pregnancy. In Human reproduction update, 27, 570-583. doi:10.1093/humupd/dmaa060. https://pubmed.ncbi.nlm.nih.gov/33434267/
2. Cheng, Weike, Fu, Yong, Lin, Zexin, Yu, Bin, Liu, Guanqiao. 2023. Lipoteichoic acid restrains macrophage senescence via β-catenin/FOXO1/REDD1 pathway in age-related osteoporosis. In Aging cell, 23, e14072. doi:10.1111/acel.14072. https://pubmed.ncbi.nlm.nih.gov/38126583/
3. Pan, Quan, Gao, Mingming, Kim, DaMi, Qi, Yajuan, Guo, Shaodong. 2023. Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation. In Cellular and molecular gastroenterology and hepatology, 17, 41-58. doi:10.1016/j.jcmgh.2023.08.013. https://pubmed.ncbi.nlm.nih.gov/37678798/
4. Xin, Zhenlong, Ma, Zhiqiang, Hu, Wei, Jia, Guozhan, Yang, Yang. 2017. FOXO1/3: Potential suppressors of fibrosis. In Ageing research reviews, 41, 42-52. doi:10.1016/j.arr.2017.11.002. https://pubmed.ncbi.nlm.nih.gov/29138094/
5. Shi, Feiyu, Li, Tian, Liu, Zhi, Xia, Hongping, She, Junjun. 2017. FOXO1: Another avenue for treating digestive malignancy? In Seminars in cancer biology, 50, 124-131. doi:10.1016/j.semcancer.2017.09.009. https://pubmed.ncbi.nlm.nih.gov/28965871/
6. Ebrahimnezhad, Mohammad, Natami, Mohammad, Bakhtiari, Ghazaleh Hafezi, Yousefi, Bahman, Majidinia, Maryam. 2023. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 169, 115900. doi:10.1016/j.biopha.2023.115900. https://pubmed.ncbi.nlm.nih.gov/37981461/
7. Benchoula, Khaled, Arya, Aditya, Parhar, Ishwar S, Hwa, Wong Eng. 2020. FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity. In European journal of pharmacology, 891, 173758. doi:10.1016/j.ejphar.2020.173758. https://pubmed.ncbi.nlm.nih.gov/33249079/
8. Shao, Fei, Liu, Zhen, Wei, Qinglin, Fan, Zusen, Wang, Shuo. 2023. FOXO1 orchestrates the intestinal homeostasis via neuronal signaling in group 3 innate lymphoid cells. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20230133. https://pubmed.ncbi.nlm.nih.gov/37549024/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
